title: Strategies to eradicate rubella in the English-speaking Caribbean.
abstract: OBJECTIVE
  This report presents the strategies used to eradicate rubella in the Caribbean region and the challenges faced by that effort.
  
  
  METHODS
  Using the surveillance system for measles cases that was instituted in all countries in the Caribbean Community (CARICOM), 12 countries confirmed cases of rubella between 1992 and 1996. Rubella infections occurred in epidemic proportions in 6 countries during that period.
  
  
  RESULTS
  On the basis of the rubella prevalence data, rubella-congenital rubella syndrome (CRS) cost-benefit analysis, and cost-effectiveness of the mass campaign, the Council for Human and Social Development of CARICOM resolved, on April 21, 1998, that every effort would be made to eradicate rubella, as well as to prevent the occurrence of new cases of CRS by the end of 2000. Using the Pan American Health Organization's template for measles eradication, CARICOM proposed and implemented the main strategies for rubella and CRS eradication, and rubella mass campaigns were conducted in 18 countries. The target population, which included males and females (aged 20-40 years), was approximately 2.2 million.
  
  
  CONCLUSIONS
  The major challenges for rubella eradication are attaining high vaccine coverage in the adult population and maintaining an effective surveillance system able to detect rubella activity.
authors.affiliation: Division of Vaccines and Immunization, Pan American Health Organization, Port of Spain, Trinidad and Tobago.
authors.forename: B
authors.initials: B
authors.lastname: Irons
authors.forename: M J
authors.initials: MJ
authors.lastname: Lewis
authors.forename: M
authors.initials: M
authors.lastname: Dahl-Regis
authors.forename: C
authors.initials: C
authors.lastname: Castillo-Solórzano
authors.forename: P A
authors.initials: PA
authors.lastname: Carrasco
authors.forename: C A
authors.initials: CA
authors.lastname: de Quadros
mesh_terms: D000293:Adolescent; D000328:Adult; D017691:Caribbean Region / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D008297:Male; D011159:Population Surveillance; D015995:Prevalence; D012409:Rubella / Q000453:epidemiology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage*; D014611:Vaccination
chemical_list: D012411:Rubella Vaccine